» Articles » PMID: 1419754

Increased Sensory Neuropeptides in Nodular Prurigo: a Quantitative Immunohistochemical Analysis

Overview
Journal Br J Dermatol
Specialty Dermatology
Date 1992 Oct 1
PMID 1419754
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Seven patients with nodular prurigo, five patients with lichenified eczema and seven control volunteers were studied immunohistochemically using antisera to the pan-neuronal marker protein gene product 9.5 (PGP), and the neuropeptides calcitonin gene-related peptide (CGRP), substance P (SP), tyrosine hydroxylase (TH), vasoactive intestinal polypeptide (VIP) and the C-flanking region of neuropeptide Y (C-PON). PGP-, CGRP- and SP-immunoreactivities were also evaluated using image analysis quantification, and the data compared by statistical analysis. No significant changes were noted in the lichenified skin of patients with chronic eczema, compared with the control groups. In contrast, a significant increase in PGP immunoreactive nerve fibers was seen in lesional skin of all nodular prurigo cases studied, when compared with non-lesional skin from the same patient or from control subjects (P < 0.001). In one case massive neural hyperplasia was also identified. Staining for CGRP and SP showed a large increase of immunoreactive nerves in lesional skin of nodular prurigo patients, which closely paralleled that of PGP. Staining with VIP, C-PON and TH was similar in both lesional and non-lesional skin. These results indicate that neural changes in nodular prurigo are associated with an increase of sensory neuropeptides, which could be related to the intense pruritus which accompanies nodular prurigo. The absence of significant changes in lichenified skin suggests that the increase in CGRP- and SP-immunoreactive nerve fibres is a characteristic feature of nodular prurigo and may be important in its pathogenesis.

Citing Articles

Molecular mechanisms of pruritus in prurigo nodularis.

Shao Y, Wang D, Zhu Y, Xiao Z, Jin T, Peng L Front Immunol. 2023; 14:1301817.

PMID: 38077377 PMC: 10701428. DOI: 10.3389/fimmu.2023.1301817.


Neuroimmune interplay during type 2 inflammation: Symptoms, mechanisms, and therapeutic targets in atopic diseases.

Kim B, Rothenberg M, Sun X, Bachert C, Artis D, Zaheer R J Allergy Clin Immunol. 2023; 153(4):879-893.

PMID: 37634890 PMC: 11215634. DOI: 10.1016/j.jaci.2023.08.017.


Prolonged Antipruritic Effect of Botulinum Toxin Type A on Cowhage-induced Itch: A Randomized, Single-blind, Placebo-controlled Trial.

Nattkemper L, Does A, Stull C, Lavery M, Valdes-Rodriguez R, McGregory M Acta Derm Venereol. 2023; 103:adv6581.

PMID: 37584094 PMC: 10442928. DOI: 10.2340/actadv.v103.6581.


Chronic Nodular Prurigo: An Update on the Pathogenesis and Treatment.

Wong L, Yen Y Int J Mol Sci. 2022; 23(20).

PMID: 36293248 PMC: 9604302. DOI: 10.3390/ijms232012390.


Pruritus: A Sensory Symptom Generated in Cutaneous Immuno-Neuronal Crosstalk.

Szollosi A, Olah A, Lisztes E, Griger Z, Toth B Front Pharmacol. 2022; 13:745658.

PMID: 35321329 PMC: 8937025. DOI: 10.3389/fphar.2022.745658.